The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The financial toxicity order set: A simple intervention to better connect patients with resources.
 
Bridgette Thom
Stock and Other Ownership Interests - AADi (I); AADi (I); Adma Pharma (I); Arcus Biosciences (I); Autolus (I); Autolus (I); Avadel Pharmaceuticals (I); Avidity Biosciences (I); Axonics Modulation Technologies (I); Caladrius Biosciences (I); Chimerix (I); Concert Pharmaceuticals (I); Curis (I); DermTech (I); Halozyme (I); IMV (I); Iovance Biotherapeutics (I); Lipocine (I); Mediwound (I); MEI Pharma (I); Mereo BioPharma (I); Oncternal Therapeutics (I); Pacific Business Group on Health (I); Processa Pharmaceuticals (I); Qiagen (I); Revance Therapeutics (I); Sierra Oncology (I); Sutro Biopharma (I); Zimmer BioMet (I)
 
Fumiko Chino
No Relationships to Disclose
 
Joshua Allen-Dicker
No Relationships to Disclose
 
Nisha Rao
No Relationships to Disclose
 
Stephanie Doyle
No Relationships to Disclose
 
Allison Liebhaber
No Relationships to Disclose
 
Stefania Sokolowski
No Relationships to Disclose
 
Tiffanny Newman
No Relationships to Disclose
 
Nadeem Abu-Rustum
Honoraria - NCCN; Prime Oncology
Research Funding - GRAIL (Inst)
Travel, Accommodations, Expenses - Prime Oncology
 
Francesca Gany
No Relationships to Disclose
 
Emeline Mariam Aviki
No Relationships to Disclose